Description
CJC-1295 and Ipamorelin are research peptides widely investigated for their complementary roles in growth hormone (GH) regulation and physiological recovery.
CJC-1295 is a growth hormone-releasing hormone (GHRH) analog that interacts with GHRH receptors to promote the body’s natural release of growth hormone. Research suggests it may help enhance GH pulsatility, a key factor in cellular regeneration, recovery processes, and metabolic function.
Ipamorelin is a highly selective growth hormone secretagogue (GHS) that acts as an agonist of the ghrelin/GH secretagogue receptor (GHS-R). Studies indicate that it may support muscle recovery, bone health, metabolic activity, insulin regulation, and gastrointestinal motility while encouraging natural GH secretion.
When studied in combination, CJC-1295 and Ipamorelin have demonstrated synergistic effects, potentially enhancing growth hormone release while helping maintain more stable hormone levels. This peptide combination is commonly researched for its potential applications in muscle development, recovery support, metabolic performance, and overall endocrine system regulation.
Package Includes
- (1) Vial of Lyophilized Peptide Powder
Important Notes
- Bacteriostatic water is required for reconstitution and is not included.
- Syringes and additional laboratory supplies are not included.
- All peptides are intended exclusively for research applications.
For research purposes only. Not intended for human consumption, medical use, diagnosis, treatment, or prevention of any disease.
